Briggs-Andrew
Position
Professor of Health Economics
Company
Health Economics and Health Technology Assessment, University of Glasgow
Location
Glasgow UNITED KINGDOM
Bio

Andrew Briggs, DPhil

Andrew Briggs, DPhil, has extensive experience conducting economic evaluation analyses globally, and developing cost-effectiveness models across health systems. Andrew has a DPhil in Health Economics and MSc in Applied Statistics, both from the University of Oxford. He currently holds the William R Lindsay Chair of Health Economics at the University of Glasgow and has acted as advisor to the UK Department of Health, the UK National Institute of Health & Care Excellence (NICE), and a number of pharmaceutical companies. He has published extensively on the topic of cost-effectiveness analysis and economic evaluation with over 200 publications in the peer-reviewed literature. He has served on numerous committees on economic evaluation methodology and reporting, including five ISPOR Task Forces. He is an Editor at the journal Health Economics, and has previously served on the editorial boards of Value in Health and Medical Decision Making. He is also lead author of the widely cited book Decision Modelling for Health Economic Evaluation (with Karl Claxton and Mark Sculpher; Oxford University Press 2006). Following a sabbatical at Center for Health Policy & Outcomes, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center (MSKCC), with Dr. Peter Bach, Andrew continues to work half-time at MSKCC as a Visiting Investigator.

Official ISPOR Bio

Andrew Briggs, DPhil, has extensive experience conducting economic evaluation analyses globally, and developing cost-effectiveness models across health systems. Andrew has a DPhil in Health Economics and MSc in Applied Statistics, both from the University of Oxford. He currently holds the William R Lindsay Chair of Health Economics at the University of Glasgow and has acted as Advisor to the UK Department of Health, the UK National Institute of Health & Care Excellence (NICE), and a number of pharmaceutical companies. He has published extensively on the topic of cost-effectiveness analysis and economic evaluation with over 200 publications in the peer-reviewed literature. He has served on numerous committees on economic evaluation methodology and reporting, including five ISPOR Task Forces. He is an Editor at the journal Health Economics, and has previously served on the editorial boards of Value in Health and Medical Decision Making. He is also lead author of the widely cited book Decision Modelling for Health Economic Evaluation (with Karl Claxton and Mark Sculpher; Oxford University Press 2006). Following a sabbatical at Center for Health Policy & Outcomes, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center (MSKCC), with Dr. Peter Bach, Andrew continues to work half-time at MSKCC as a Visiting Investigator.

Scientific Topics
None yet.